Detalles de la búsqueda
1.
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lancet Oncol
; 23(12): e544-e551, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455583
2.
Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.
Cancer Control
; 28: 10732748211047117, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34565216
3.
Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report.
BMC Infect Dis
; 21(1): 1148, 2021 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758746
4.
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Int J Cancer
; 144(7): 1713-1722, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30192385
5.
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
Br J Cancer
; 121(8): 690-698, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527689
6.
Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
Eur Arch Otorhinolaryngol
; 274(2): 1067-1078, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27738820
7.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how?
Lancet Oncol
; 20(2): e66, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30712799
8.
SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes.
Cancers (Basel)
; 14(13)2022 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35805058
9.
Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer.
Cancers (Basel)
; 14(2)2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053569
10.
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Cancers (Basel)
; 14(8)2022 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35454830
11.
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Oral Oncol
; 126: 105736, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121396
12.
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
Oral Oncol
; 114: 105158, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508707
13.
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Front Oncol
; 10: 1417, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974150
14.
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.
Liver Cancer
; 7(1): 40-54, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29662832
15.
Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma - How far have we achieved?
Crit Rev Oncol Hematol
; 114: 13-23, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28477740
16.
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
Medicine (Baltimore)
; 96(15): e6518, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28403082
17.
Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.
Oncotarget
; 8(3): 5292-5308, 2017 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28029657
18.
Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
Clin Oncol (R Coll Radiol)
; 28(8): e52-60, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27235379
19.
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
PLoS One
; 11(6): e0157969, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27341634
20.
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma.
Onco Targets Ther
; 8: 3457-64, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26640386